1,25(OH)2vitamin D3 stimulates myogenic differentiation by inhibiting cell proliferation and modulating the expression of promyogenic growth factors and myostatin in C2C12 skeletal muscle cells

Endocrinology

Volumn 152, Issue 8, 2011, Pages 2976-2986

  Garcia, Leah A ^a   King, Keisha K ^a,b   Ferrini, Monica G ^a,b   Norris, Keith C ^a,b   Artaza, Jorge N ^a,b  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; FOLLISTATIN; GROWTH DIFFERENTIATION FACTOR; GROWTH DIFFERENTIATION FACTOR 11; MYOSTATIN; PLACEBO; SOMATOMEDIN B; SOMATOMEDIN C; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; DRUG ACTIVITY; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; BONE MORPHOGENETIC PROTEINS; CALCITRIOL; CELL PROLIFERATION; CELLS, CULTURED; GENE EXPRESSION REGULATION; GROWTH DIFFERENTIATION FACTORS; INSULIN-LIKE GROWTH FACTOR II; MICE; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; MYOD PROTEIN; MYOSTATIN; RECEPTORS, CALCITRIOL;

EID: 79960711583     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-0159     Document Type: Article

References (38)

1. Holick MF 2006 The role of vitamin D for bone health and fracture prevention. Curr Osteoporos Rep 4:96-102 (Pubitemid 44623931)
2. Glerup H, Mikkelsen K, Poulsen L, Hass E, Overbeck S, Andersen H, Charles P, Eriksen EF 2000 Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement. Calcif Tissue Int 66:419-424 (Pubitemid 30368371)
3. Bordelon P, Ghetu MV, Langan RC 2009 Recognition and management of vitamin D deficiency. Am Fam Physician 80:841-846
4. Ceglia L 2009 Vitamin D and its role in skeletal muscle. Curr Opin Clin Nutr Metab Care 12:628-633
5. Wicherts IS, van Schoor NM, Boeke AJ, Visser M, Deeg DJ, Smit J, Knol DL, Lips P 2007 Vitamin D status predicts physical performance and its decline in older persons. J Clin Endocrinol Metab 92:2058-2065 (Pubitemid 46997101)
6. Bischoff-Ferrari HA 2010 Vitamin D and fracture prevention. Endocrinol Metab Clin North Am 39:347-353, table of contents
7. Bischoff-Ferrari HA, Dietrich T, Orav EJ, Hu FB, Zhang Y, Karlson EW, Dawson-Hughes B 2004 Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or 60 y. Am J Clin Nutr 80:752-758 (Pubitemid 41115542)
8. Heath KM, Elovic EP 2006 Vitamin D deficiency: implications in the rehabilitation setting. Am J Phys Med Rehabil 85:916-923 (Pubitemid 44690755)
9. Bischoff-Ferrari HA, Borchers M, Gudat F, Dürmüller U, Stähelin HB, Dick W 2004 Vitamin D receptor expression in human muscle tissue decreases with age. J Bone Miner Res 19:265-269 (Pubitemid 38116740)
10. Snijder MB, van Schoor NM, Pluijm SM, van Dam RM, Visser M, Lips P 2006 Vitamin D status in relation to one-year risk of recurrent falling in older men and women. J Clin Endocrinol Metab 91:2980-2985 (Pubitemid 44271745)
11. Ceglia L 2008 Vitamin D and skeletal muscle tissue and function. Mol Aspects Med. 29:407-414
12. Bouillon R, Bischoff-Ferrari H, Willett W 2008 Vitamin D and health: perspectives from mice and man. J Bone Miner Res 23:974-979 (Pubitemid 351915717)
13. Endo I, Inoue D, Mitsui T, Umaki Y, Akaike M, Yoshizawa T, Kato S, Matsumoto T 2003 Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology 144:5138-5144 (Pubitemid 37476038)
14. Holick MF 2011 Vitamin D: evolutionary, physiological and health perspectives. Curr Drug Targets 12:4-18
15. Willett M, Cowan JL, Vlasak M, Coldwell MJ, Morley SJ 2009 Inhibition of mammalian target of rapamycin (mTOR) signalling in C2C12 myoblasts prevents myogenic differentiation without affecting the hyperphosphorylation of 4E-BP1. Cell Signal 21:1504-1512
16. Artaza JN, Bhasin S, Mallidis C, Taylor W, Ma K, Gonzalez-Cadavid NF 2002 Endogenous expression and localization of myostatin and its relation to myosin heavy chain distribution in C2C12 skeletal muscle cells. J Cell Physiol 190:170-179 (Pubitemid 34030568)
17. Taylor WE, Bhasin S, Artaza J, Byhower F, Azam M, Willard Jr DH, Kull Jr FC, Gonzalez-Cadavid N 2001 Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells. Am J Physiol Endocrinol Metab 280:E221-E228
18. Artaza JN, Sirad F, Ferrini MG, Norris KC 2010 1,25(OH)2 vitamin D3 inhibits cell proliferation by promoting cell cycle arrest without inducing apoptosis and modifies cell morphology of mesenchymal multipotent cells. J Steroid Biochem Mol Biol 119:73-83
19. Artaza JN, Norris KC 2009 Vitamin D reduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells. J Endocrinol 200:207-221
20. Cardús A, Parisi E, Gallego C, Aldea M, Fernández E, Valdivielso JM 2006 1,25-Dihydroxyvitamin D3 stimulates vascular smooth muscle cell proliferation through a VEGF-mediated pathway. Kidney Int 69:1377-1384
21. Khanna-Jain R, Vuorinen A, Sándor GK, Suuronen R, Miettinen S 2010 Vitamin D(3) metabolites induce osteogenic differentiation in humandental pulp andhumandental follicle cells. J Steroid Biochem Mol Biol 122:133-141
22. Barbosa EM, Nonogaki S, Katayama ML, Folgueira MA, Alves VF, Brentani MM 2004 Vitamin D3 modulation of plasminogen activator inhibitor type-1 in human breast carcinomas under organ culture. Virchows Arch 444:175-182 (Pubitemid 38315297)
23. Ramirez AM, Wongtrakool C, Welch T, Steinmeyer A, Zügel U, Roman J 2010 Vitamin D inhibition of pro-fibrotic effects of transforming growth factor β1 in lung fibroblasts and epithelial cells. J Steroid Biochem Mol Biol 118:142-150
24. Artaza JN, Singh R, Ferrini MG, Braga M, Tsao J, Gonzalez-Cadavid NF 2008 Myostatin promotes a fibrotic phenotypic switch in multipotent C3H 10T1/2 cells without affecting their differentiation into myofibroblasts. J Endocrinol 196:235-249 (Pubitemid 351298509)
25. Artaza JN, Bhasin S, Magee TR, Reisz-Porszasz S, Shen R, Groome NP, Meerasahib MF, Fareez MM, Gonzalez-Cadavid NF 2005 Myostatin inhibits myogenesis and promotes adipogenesis in C3H 10T(1/2) mesenchymal multipotent cells. Endocrinology 146:3547-3557 (Pubitemid 41058126)
26. Pike JW, Meyer MB 2010 The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D(3). Endocrinol Metab Clin North Am 39:255-269, table of contents
27. Weintraub H 1993 The MyoD family and myogenesis-redundancy, networks, and thresholds. Cell 75:1241-1244 (Pubitemid 24021898)
28. Florini JR, Ewton DZ, Magri KA, Mangiacapra FJ 1993 IGFs and muscle differentiation. Adv Exp Med Biol 343:319-326 (Pubitemid 24059301)
29. Florini JR, Magri KA, Ewton DZ, James PL, Grindstaff K, Rotwein PS 1991 Spontaneous differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II. J Biol Chem 266:15917-15923 (Pubitemid 21907745)
30. Lawlor MA, Rotwein P 2000 Insulin-like growth factor-mediated muscle cell survival: central roles for Akt and cyclin-dependent kinase inhibitor p21. Mol Cell Biol 23:8983-8995 (Pubitemid 32245928)
31. Wilson EM, Hsieh MM, Rotwein P 2003 Autocrine growth factor signaling by insulin-like growth factor-II mediates MyoD-stimulated myocyte maturation. J Biol Chem 278:41109-41113 (Pubitemid 37280935)
32. Wilson EM, Rotwein P 2006 Control of MyoD function during initiation of muscle differentiation by an autocrine signaling pathway activated by insulin-like growth factor-II. J Biol Chem 281:29962-29971 (Pubitemid 44537004)
33. McPherron AC, Lawler AM, Lee SJ 1997 Regulation of skeletal muscle mass in mice by a new TGF-β superfamily member. Nature 387:83-90 (Pubitemid 27202654)
34. McPherron AC, Lee SJ 1997 Double muscling in cattle due to mutations in the myostatin gene. Proc Natl Acad Sci USA 94:12457-12461 (Pubitemid 27492550)
35. Lee SJ, McPherron AC 2001 Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci USA 98:9306-9311 (Pubitemid 32743912)
36. McPherron AC, Huynh TV, Lee SJ 2009 Redundancy of myostatin and growth/differentiation factor 11 function. BMC Dev Biol 19:9-24
37. Amthor H, Nicholas G, McKinnell I, Kemp CF, Sharma M, Kambadur R, Patel K 2004 Follistatin complexes myostatin and antagonises myostatin-mediated inhibition of myogenesis. Dev Biol 270:19-30 (Pubitemid 38596926)
38. Lee SJ, Lee YS, Zimmers TA, Soleimani A, Matzuk MM, Tsuchida K, Cohn RD, Barton ER 2010 Regulation of muscle mass by follistatin and activins. Mol Endocrinol 2010 24:1998-2008